80. Resistance to thyroid hormone Clinical trials / Disease details


Clinical trial : 1 Drugs : 5 - (DrugBank : 3) / Drug target genes : 3 - Drug target pathways : 3

  
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04868045
(ClinicalTrials.gov)
April 27, 202128/4/2021Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid CancerEvaluation of The Development of Central Resistance to Thyroid Hormone After Prolonged Exposure to Excess Thyroid Hormone in Thyroid Cancer PatientsThyroid CancerDrug: Thyrotropin Releasing Hormone (TRH);Drug: levothyroxine;Other: Hypothyroidism QOL questionnaireMemorial Sloan Kettering Cancer CenterNULLWithdrawn18 YearsN/AAll0Phase 1United States